SF Opera singer enters clinical trials for cancer of lung cancer

November 11, 2010

SAN FRANCISCO (KGO)--there is an update to the San Francisco Opera singer Zheng Cao face battle with lung cancer phase four. The drug has worked to keep it alive, it doesn't work so well. It is therefore now take part in a clinical trial. This allows the trip to follow ABC7, as a woman who never smoked, to raise awareness of the need for research in lung cancer.

CaO is enthusiastic for news from the oncologist, Dr. Heather Wakelee from Stanford University Medical Center. Blood examinations of CaO returned almost normal, after the first two weeks of a new drug called trivial XL184 in a clinical trial.

Opera singer had months to live, but new treatments eliminate cancerous tumors

27 December 2010

"One and a half years," says Larson. -You do not have regrown of tumours and played any new tumours.

Drugs and other treatments, tumors elsewhere in the House of Zheng significantly decrease or disappear. Cancer under control, it returns to the stage. But while the stage four cancer of the lungs is verifiable, remains incurable.

But if something happened to Zheng, know that Favorites can only enable recordings to the amenities of singing.